 | • レポートコード：QY2207C3457 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の眼がん治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼がん治療の世界市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の眼がん治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの眼がん治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの眼がん治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 眼がん治療のグローバル主要メーカーには、Novartis AG、Spectrum Pharmaceuticals,Inc、GlaxoSmithKline plc、Bayer AG、Amgen ,Inc、Takeda Pharmaceuticals Company Limited、Eli Lilly and Company、AstraZeneca、F.Hoffmann-La Roche Ltd、Janssen Global Services ,LLC、Sanofi、Abbvie ,Inc、Pfizer ,Inc、Merck & Co,Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 眼がん治療市場は、種類と用途によって区分されます。世界の眼がん治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口、静脈内、熱帯、その他 【用途別セグメント】 病院、診療所、がんセンター、診断センター、外来外科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 眼がん治療製品概要 - 種類別市場（経口、静脈内、熱帯、その他） - 用途別市場（病院、診療所、がんセンター、診断センター、外来外科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の眼がん治療販売量予測2017-2028 - 世界の眼がん治療売上予測2017-2028 - 眼がん治療の地域別販売量 - 眼がん治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別眼がん治療販売量 - 主要メーカー別眼がん治療売上 - 主要メーカー別眼がん治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口、静脈内、熱帯、その他） - 眼がん治療の種類別販売量 - 眼がん治療の種類別売上 - 眼がん治療の種類別価格 ・用途別市場規模（病院、診療所、がんセンター、診断センター、外来外科センター、その他） - 眼がん治療の用途別販売量 - 眼がん治療の用途別売上 - 眼がん治療の用途別価格 ・北米市場 - 北米の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの眼がん治療市場規模（種類別、用途別） - 主要国別の眼がん治療市場規模（トルコ、サウジアラビア） ・企業情報 Novartis AG、Spectrum Pharmaceuticals,Inc、GlaxoSmithKline plc、Bayer AG、Amgen ,Inc、Takeda Pharmaceuticals Company Limited、Eli Lilly and Company、AstraZeneca、F.Hoffmann-La Roche Ltd、Janssen Global Services ,LLC、Sanofi、Abbvie ,Inc、Pfizer ,Inc、Merck & Co,Inc ・産業チェーン及び販売チャネル分析 - 眼がん治療の産業チェーン分析 - 眼がん治療の原材料 - 眼がん治療の生産プロセス - 眼がん治療の販売及びマーケティング - 眼がん治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 眼がん治療の産業動向 - 眼がん治療のマーケットドライバー - 眼がん治療の課題 - 眼がん治療の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Eye Cancer Treatment Market
The global Eye Cancer Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Oral accounting for % of the Eye Cancer Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Eye Cancer Treatment market size is valued at US$ million in 2021, while the North America and Europe Eye Cancer Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Eye Cancer Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eye Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eye Cancer Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eye Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eye Cancer Treatment market.
Global Eye Cancer Treatment Scope and Market Size
Eye Cancer Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Eye Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Intravenous
Tropical
Others
Segment by Application
Hospital
Clinics
Cancer Centers
Diagnostic Centers
Ambulatory Surgical Centers
Others
By Company
Novartis AG
Spectrum Pharmaceuticals,Inc
GlaxoSmithKline plc
Bayer AG
Amgen ,Inc
Takeda Pharmaceuticals Company Limited
Eli Lilly and Company
AstraZeneca
F.Hoffmann-La Roche Ltd
Janssen Global Services ,LLC
Sanofi
Abbvie ,Inc
Pfizer ,Inc
Merck & Co,Inc
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eye Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Tropical
1.2.5 Others
1.3 Market by Application
1.3.1 Global Eye Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Cancer Centers
1.3.5 Diagnostic Centers
1.3.6 Ambulatory Surgical Centers
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Eye Cancer Treatment Market Perspective (2017-2028)
2.2 Eye Cancer Treatment Growth Trends by Region
2.2.1 Eye Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Eye Cancer Treatment Historic Market Size by Region (2017-2022)
2.2.3 Eye Cancer Treatment Forecasted Market Size by Region (2023-2028)
2.3 Eye Cancer Treatment Market Dynamics
2.3.1 Eye Cancer Treatment Industry Trends
2.3.2 Eye Cancer Treatment Market Drivers
2.3.3 Eye Cancer Treatment Market Challenges
2.3.4 Eye Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eye Cancer Treatment Players by Revenue
3.1.1 Global Top Eye Cancer Treatment Players by Revenue (2017-2022)
3.1.2 Global Eye Cancer Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Eye Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eye Cancer Treatment Revenue
3.4 Global Eye Cancer Treatment Market Concentration Ratio
3.4.1 Global Eye Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eye Cancer Treatment Revenue in 2021
3.5 Eye Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Eye Cancer Treatment Product Solution and Service
3.7 Date of Enter into Eye Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eye Cancer Treatment Breakdown Data by Type
4.1 Global Eye Cancer Treatment Historic Market Size by Type (2017-2022)
4.2 Global Eye Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Eye Cancer Treatment Breakdown Data by Application
5.1 Global Eye Cancer Treatment Historic Market Size by Application (2017-2022)
5.2 Global Eye Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Eye Cancer Treatment Market Size (2017-2028)
6.2 North America Eye Cancer Treatment Market Size by Type
6.2.1 North America Eye Cancer Treatment Market Size by Type (2017-2022)
6.2.2 North America Eye Cancer Treatment Market Size by Type (2023-2028)
6.2.3 North America Eye Cancer Treatment Market Share by Type (2017-2028)
6.3 North America Eye Cancer Treatment Market Size by Application
6.3.1 North America Eye Cancer Treatment Market Size by Application (2017-2022)
6.3.2 North America Eye Cancer Treatment Market Size by Application (2023-2028)
6.3.3 North America Eye Cancer Treatment Market Share by Application (2017-2028)
6.4 North America Eye Cancer Treatment Market Size by Country
6.4.1 North America Eye Cancer Treatment Market Size by Country (2017-2022)
6.4.2 North America Eye Cancer Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Eye Cancer Treatment Market Size (2017-2028)
7.2 Europe Eye Cancer Treatment Market Size by Type
7.2.1 Europe Eye Cancer Treatment Market Size by Type (2017-2022)
7.2.2 Europe Eye Cancer Treatment Market Size by Type (2023-2028)
7.2.3 Europe Eye Cancer Treatment Market Share by Type (2017-2028)
7.3 Europe Eye Cancer Treatment Market Size by Application
7.3.1 Europe Eye Cancer Treatment Market Size by Application (2017-2022)
7.3.2 Europe Eye Cancer Treatment Market Size by Application (2023-2028)
7.3.3 Europe Eye Cancer Treatment Market Share by Application (2017-2028)
7.4 Europe Eye Cancer Treatment Market Size by Country
7.4.1 Europe Eye Cancer Treatment Market Size by Country (2017-2022)
7.4.2 Europe Eye Cancer Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eye Cancer Treatment Market Size (2017-2028)
8.2 Asia-Pacific Eye Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Eye Cancer Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Eye Cancer Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Eye Cancer Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Eye Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Eye Cancer Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Eye Cancer Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Eye Cancer Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Eye Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Eye Cancer Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Eye Cancer Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Eye Cancer Treatment Market Size (2017-2028)
9.2 Latin America Eye Cancer Treatment Market Size by Type
9.2.1 Latin America Eye Cancer Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Eye Cancer Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Eye Cancer Treatment Market Share by Type (2017-2028)
9.3 Latin America Eye Cancer Treatment Market Size by Application
9.3.1 Latin America Eye Cancer Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Eye Cancer Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Eye Cancer Treatment Market Share by Application (2017-2028)
9.4 Latin America Eye Cancer Treatment Market Size by Country
9.4.1 Latin America Eye Cancer Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Eye Cancer Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eye Cancer Treatment Market Size (2017-2028)
10.2 Middle East & Africa Eye Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Eye Cancer Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Eye Cancer Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Eye Cancer Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Eye Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Eye Cancer Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Eye Cancer Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Eye Cancer Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Eye Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Eye Cancer Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Eye Cancer Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Eye Cancer Treatment Introduction
11.1.4 Novartis AG Revenue in Eye Cancer Treatment Business (2017-2022)
11.1.5 Novartis AG Recent Developments
11.2 Spectrum Pharmaceuticals,Inc
11.2.1 Spectrum Pharmaceuticals,Inc Company Details
11.2.2 Spectrum Pharmaceuticals,Inc Business Overview
11.2.3 Spectrum Pharmaceuticals,Inc Eye Cancer Treatment Introduction
11.2.4 Spectrum Pharmaceuticals,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.2.5 Spectrum Pharmaceuticals,Inc Recent Developments
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Eye Cancer Treatment Introduction
11.3.4 GlaxoSmithKline plc Revenue in Eye Cancer Treatment Business (2017-2022)
11.3.5 GlaxoSmithKline plc Recent Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Eye Cancer Treatment Introduction
11.4.4 Bayer AG Revenue in Eye Cancer Treatment Business (2017-2022)
11.4.5 Bayer AG Recent Developments
11.5 Amgen ,Inc
11.5.1 Amgen ,Inc Company Details
11.5.2 Amgen ,Inc Business Overview
11.5.3 Amgen ,Inc Eye Cancer Treatment Introduction
11.5.4 Amgen ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.5.5 Amgen ,Inc Recent Developments
11.6 Takeda Pharmaceuticals Company Limited
11.6.1 Takeda Pharmaceuticals Company Limited Company Details
11.6.2 Takeda Pharmaceuticals Company Limited Business Overview
11.6.3 Takeda Pharmaceuticals Company Limited Eye Cancer Treatment Introduction
11.6.4 Takeda Pharmaceuticals Company Limited Revenue in Eye Cancer Treatment Business (2017-2022)
11.6.5 Takeda Pharmaceuticals Company Limited Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Eye Cancer Treatment Introduction
11.7.4 Eli Lilly and Company Revenue in Eye Cancer Treatment Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Eye Cancer Treatment Introduction
11.8.4 AstraZeneca Revenue in Eye Cancer Treatment Business (2017-2022)
11.8.5 AstraZeneca Recent Developments
11.9 F.Hoffmann-La Roche Ltd
11.9.1 F.Hoffmann-La Roche Ltd Company Details
11.9.2 F.Hoffmann-La Roche Ltd Business Overview
11.9.3 F.Hoffmann-La Roche Ltd Eye Cancer Treatment Introduction
11.9.4 F.Hoffmann-La Roche Ltd Revenue in Eye Cancer Treatment Business (2017-2022)
11.9.5 F.Hoffmann-La Roche Ltd Recent Developments
11.10 Janssen Global Services ,LLC
11.10.1 Janssen Global Services ,LLC Company Details
11.10.2 Janssen Global Services ,LLC Business Overview
11.10.3 Janssen Global Services ,LLC Eye Cancer Treatment Introduction
11.10.4 Janssen Global Services ,LLC Revenue in Eye Cancer Treatment Business (2017-2022)
11.10.5 Janssen Global Services ,LLC Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Eye Cancer Treatment Introduction
11.11.4 Sanofi Revenue in Eye Cancer Treatment Business (2017-2022)
11.11.5 Sanofi Recent Developments
11.12 Abbvie ,Inc
11.12.1 Abbvie ,Inc Company Details
11.12.2 Abbvie ,Inc Business Overview
11.12.3 Abbvie ,Inc Eye Cancer Treatment Introduction
11.12.4 Abbvie ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.12.5 Abbvie ,Inc Recent Developments
11.13 Pfizer ,Inc
11.13.1 Pfizer ,Inc Company Details
11.13.2 Pfizer ,Inc Business Overview
11.13.3 Pfizer ,Inc Eye Cancer Treatment Introduction
11.13.4 Pfizer ,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.13.5 Pfizer ,Inc Recent Developments
11.14 Merck & Co,Inc
11.14.1 Merck & Co,Inc Company Details
11.14.2 Merck & Co,Inc Business Overview
11.14.3 Merck & Co,Inc Eye Cancer Treatment Introduction
11.14.4 Merck & Co,Inc Revenue in Eye Cancer Treatment Business (2017-2022)
11.14.5 Merck & Co,Inc Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer